Continuous Ward Monitoring With the GE Portrait Mobile Monitoring Solution: the COSMOS Trial

Description

The investigators plan to determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery.

Conditions

Postoperative Complications

Talk to us

Study Overview

On this page

Study Details

Study overview

The investigators plan to determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery.

Continuous Ward Monitoring With the GE Portrait Mobile Monitoring Solution: the COSMOS Trial

Continuous Ward Monitoring With the GE Portrait Mobile Monitoring Solution: the COSMOS Trial

Condition
Postoperative Complications
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic Foundation, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Are expected to be admitted to one of the wards equipped with the GE Portrait Mobile Monitoring Solution;
  • 2. Are ≥18 years old;
  • 3. Are designated American Society of Anesthesiologists physical status 1-4;
  • 4. Are scheduled for major noncardiac surgery lasting at least 1.5 hours;
  • 5. Are expected to remain hospitalized at least one postoperative night;
  • 6. Are expected to have general or neuraxial anesthesia.
  • 1. Have language, vision, or hearing impairments that might compromise continuous monitoring;
  • 2. Are designated Do Not Resuscitate, hospice, or receiving end of life care;
  • 3. Are expected to have telemetry monitoring;
  • 4. Have previously participated in the study.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Cleveland Clinic,

Daniel I Sessler, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

2026-06-01